Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey
暂无分享,去创建一个
[1] S. Hutchinson,et al. A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[2] C. Stoicescu,et al. Developing Effective Health Interventions for Women Who Inject Drugs: Key Areas and Recommendations for Program Development and Policy , 2012, Advances in preventive medicine.
[3] J. Parry,et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. , 2011, Addiction.
[4] H. Wand,et al. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. , 2010, The International journal on drug policy.
[5] M. Farrell,et al. Meta-analysis of drug-related deaths soon after release from prison , 2010, Addiction.
[6] C. Gaudy-Graffin,et al. Use of an Anti-Hepatitis C Virus (HCV) IgG Avidity Assay To Identify Recent HCV Infection , 2010, Journal of Clinical Microbiology.
[7] J. Parry,et al. Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size , 2009, Epidemiology and Infection.
[8] J. Parry,et al. Prevalence and incidence of hepatitis C in injecting drug users attending genitourinary medicine clinics , 2008, Epidemiology and Infection.
[9] J. Parry,et al. Diagnosis of acute hepatitis C virus infection and estimated incidence in low‐ and high‐risk English populations , 2008, Journal of viral hepatitis.
[10] J. Parry,et al. Assays for the detection of recent infections with human immunodeficiency virus type 1. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] M. Abou-Saleh,et al. The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned , 2008, Harm reduction journal.
[12] E. Pontali,et al. Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus. , 2008, International journal of prisoner health.
[13] R. Coutinho,et al. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.
[14] M. Busch,et al. Distinguishing Acute from Chronic and Resolved Hepatitis C Virus (HCV) Infections by Measurement of Anti-HCV Immunoglobulin G Avidity Index , 2007, Journal of Clinical Microbiology.
[15] J. Kaldor,et al. High hepatitis C incidence in new injecting drug users: a policy failure? , 2007, Australian and New Zealand journal of public health.
[16] J. Parry,et al. Human Immunodeficiency Virus (HIV) Antibody Avidity Testing To Identify Recent Infection in Newly Diagnosed HIV Type 1 (HIV-1)-Seropositive Persons Infected with Diverse HIV-1 Subtypes , 2006, Journal of Clinical Microbiology.
[17] Rohan Jayasuriya,et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.
[18] J. Parry,et al. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years , 2005, AIDS.
[19] J. Parry,et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study , 2004, BMJ : British Medical Journal.
[20] B. Jalaludin,et al. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south‐western Sydney, Australia , 2004, Journal of gastroenterology and hepatology.
[21] J. Tang,et al. Failure to diagnose recent hepatitis C virus infections in London injecting drug users , 2004, Journal of medical virology.
[22] J. Rich,et al. Hepatitis C infection and incarcerated populations , 2004 .
[23] J. Parry,et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots , 2003, Journal of medical virology.
[24] J. Barry,et al. Retrospective cohort study examining incidence of HIV and hepatitis C infection among injecting drug users in Dublin , 2003, Journal of epidemiology and community health.
[25] D. Vlahov,et al. Does Bleach Disinfection of Syringes Protect Against Hepatitis C Infection Among Young Adult Injection Drug Users? , 2002, Epidemiology.
[26] J. Montaner,et al. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users , 2002, Hepatology.
[27] M. Schechter,et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection , 2022 .
[28] S. Hutchinson,et al. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98. , 2001, The Journal of infection.
[29] J. Parry,et al. Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? , 2001, American journal of public health.
[30] J. Parry,et al. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. , 2000, Communicable disease and public health.
[31] R. Dwyer,et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study , 1998, BMJ.
[32] J. de Irala,et al. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. , 1996, American journal of epidemiology.
[33] E. Holmes,et al. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group. , 1995, The Journal of general virology.
[34] J. Parry,et al. HIV infection in injecting drug users attending centres in England and Wales, 1990–1991 , 1993, AIDS.
[35] J. Parry,et al. Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine , 1993, Journal of medical virology.
[36] D. Vlahov,et al. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.